ABVC BioPharma, Inc. (ABVC) vs LianBio Sponsored ADR (LIANY)

ABVC BioPharma, Inc. and LianBio Sponsored ADR are both Biotechnology companies. ABVC BioPharma, Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $34.0M). ABVC BioPharma, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 10 metrics below, LianBio Sponsored ADR leads on 7 and ABVC BioPharma, Inc. on 3.

Valuation

Metric ABVC LIANY Biotechnology median
P/E n/m 0.02 7.88
P/S 22.77 n/m 11.47
P/B 2.42 0.01 2.52
Price to free cash flow n/m 0.03 21.16
EV/EBITDA n/m 5.71 0.74
EV/Sales 24.03 n/m 10.73
Earnings yield (29.79%) 4,811.17% (28.84%)
Free cash flow yield (9.14%) 3,996.57% (23.03%)

Profitability

Metric ABVC LIANY Biotechnology median
Gross margin 99.97% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) 70.96% (57.72%)
Return on assets (39.88%) 66.19% (49.22%)
Return on invested capital (33.45%) (450.47%) 0.00%

Growth

Metric ABVC LIANY Biotechnology median
Revenue growth (TTM) 5,035.43% — 5.64%
EPS growth (last fiscal year) 7.14% 75.44% —
Revenue growth, 5-year CAGR (6.20%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 17.03 4.73
Net debt to EBITDA 0.21 7.41 0.96

Dividend

Metric ABVC LIANY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABVC LIANY Biotechnology median
Market cap 33.96m 34.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack